Tuesday, October 11, 2016 3:38:33 PM
if the ADS value didnt change based on underlying israeli shares, i of course would be happy to buy warrants that essentially act as super options (expiry several years away) - Whats not to love...
The reason they are worrisome (outside of the normal reasons, and the specific mention to the ADSs not being recognized by either exchanges..)
Is that their value is attached to israeli shares, that dilute massively upon exercise, without adjusting for dilution (as ive been told, they are not) *if they were, it wud mean that the 20 share value is pegged to an agree upon $$ value, regardless ofhow many shares it takes to reach that**
In one neat statement:
I am fine with risk, in fact, I've worked at or with funds that specialize in bio tech/pharma risk analysis, I love it and have been fortunate enough to work on my own terms from a very young age. It is not the science, or market risk that concerns me (and colleagues of mine still in the industry), it is plain and simply human greed I cannot bet against. Sure, I have, and many have made much more on this stock, and the countless other almost identical situations. It is a strategy I used in my less wealthy days - Just make sure you get out before those at the top begin cashing out...
P.S. I wrote this proactively before reading a single extra post from lastnight and I don't plan to, I am happy for normal discussion but not what I glimpsed lastnight..
As the manager of a multi-billion dollar portfolio told us once, it is those who don't shy away from contrary opinion, those that aren't afraid to be wrong in the name of true due diligence, that survive, even prosper, the longest...
Avant Technologies' Partner, Ainnova, Signs Pilot Program with Roche to Combat Diabetic Retinopathy • AVAI • Dec 4, 2024 8:00 AM
North Bay Resources Commences Fran Gold Winter Ore Shipment to Bishop Gold Mill, California • NBRI • Dec 2, 2024 9:07 AM
VAYK Reached Agreement on Terms to Acquire $1 Million Company for Disruptive Airbnb Strategy • VAYK • Dec 2, 2024 9:00 AM
ILUS Announces Completion of QIND Acquisition by Fusion Fuel (NASDAQ: HTOO) • ILUS • Nov 27, 2024 12:35 PM
Cannabix Technologies Receives Positive Testing Certification for Breath Logix Autonomous Alcohol Breathalyzer • BLO • Nov 26, 2024 8:48 AM
BioQuest, Inc. and BotMakers Expand AI Marketing Services with SpeedLeads XL and MarketScope XL. Bioquest Corp. and BotMakers, Inc. are Partnered to Expand AI Marketing Services with SpeedLead XL and MarketScope XL • BQST • Nov 26, 2024 8:00 AM